CymaBay Therapeutics
CBAY
$32.48
Share price
0.00%
Change (1 day)
221.27%
Change (1 year)
Categories
CymaBay Therapeutics (CBAY) - Net assets
Net assets on the balance sheet as of December 2023 : $0.29 B
According to CymaBay Therapeutics
's latest financial reports the company has $0.29 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
CymaBay Therapeutics - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.29 B | 708.36% |
| 2022-12-31 | $36.15 M | -72.8% |
| 2021-12-31 | $0.13 B | -6.85% |
| 2020-12-31 | $0.14 B | -23.42% |
| 2019-12-31 | $0.18 B | 9.35% |
| 2018-12-31 | $0.17 B | 100.62% |
| 2017-12-31 | $84.94 M | 2057.66% |
| 2016-12-31 | $3.93 M | -86% |
| 2015-12-31 | $28.11 M | 103% |
| 2014-12-31 | $13.85 M | -25.52% |
| 2013-12-31 | $18.59 M | -105.66% |
| 2012-12-31 | $-0.33 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 30,451.30% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 5,562.16% | 🇺🇸 USA |
 Xencor XNCR | $0.66 B | 128.95% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$0.82 B | -380.08% | 🇺🇸 USA |